Mexico: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2025

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Mexico

The Mexican prophylactic medicaments containing insulin market declined to $X in 2022, reducing by -2.2% against the previous year. The market value increased at an average annual rate of +3.2% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, the market reached the peak level at $X in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Mexico

In value terms, prophylactic medicaments containing insulin production declined to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +3.1% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 with an increase of 11% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2017; however, from 2018 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Mexico

Prophylactic medicaments containing insulin exports from Mexico amounted to X tons in 2019, almost unchanged from the previous year's figure. Over the period under review, exports faced a precipitous setback. The smallest decline of -7.3% was in 2014. Over the period under review, the exports hit record highs at X tons in 2012; however, from 2013 to 2019, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports totaled $X in 2019. Overall, exports recorded a precipitous curtailment. The smallest decline of -17.2% was in 2014. The exports peaked at $X in 2012; however, from 2013 to 2019, the exports remained at a lower figure.

Exports by Country

Guatemala (X tons) was the main destination for prophylactic medicaments containing insulin exports from Mexico, accounting for a approx. 100% share of total exports.

From 2012 to 2019, the average annual growth rate of volume to Guatemala amounted to -9.3%.

From 2012 to 2019, the average annual growth rate of value to Guatemala totaled +13.5%.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2019, remaining relatively unchanged against the previous year. Over the period under review, the export price showed prominent growth. The most prominent rate of growth was recorded in 2015 when the average export price increased by 21% against the previous year. Over the period under review, the average export prices attained the maximum in 2019 and is expected to retain growth in years to come.

As there is only one major export destination, the average price level is determined by prices for Guatemala.

From 2012 to 2019, the rate of growth in terms of prices for Guatemala amounted to +25.1% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Mexico

In 2022, prophylactic medicaments containing insulin imports into Mexico fell markedly to X tons, which is down by -87.5% against 2021. Over the period under review, imports continue to indicate a precipitous decline. The most prominent rate of growth was recorded in 2020 with an increase of 63%. Imports peaked at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports reduced markedly to $X in 2022. Overall, imports saw a sharp contraction. The pace of growth appeared the most rapid in 2020 when imports increased by 60%. Over the period under review, imports attained the maximum at $X in 2015; however, from 2016 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Germany (X tons) was the main prophylactic medicaments containing insulin supplier to Mexico, with a approx. 100% share of total imports.

From 2012 to 2022, the average annual growth rate of volume from Germany amounted to -22.6%.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Mexico.

From 2012 to 2022, the average annual growth rate of value from Germany totaled -25.9%.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, which is down by -6% against the previous year. Overall, the import price recorded a mild downturn. The pace of growth was the most pronounced in 2018 an increase of 39%. Over the period under review, average import prices attained the peak figure at $X per ton in 2015; however, from 2016 to 2022, import prices remained at a lower figure.

As there is only one major supplying country, the average price level is determined by prices for Germany.

From 2012 to 2022, the rate of growth in terms of prices for Denmark amounted to +14.5% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :